Projects

scientist
Mgr. Kristína Ferenczyová, PhD.

International

Current
  • Bridging the gap between cardiac and vascular regeneration
    Program: Horizon Europe
    Duration: 1. 1. 2024 – 31. 12. 2026

National

Current
  • Novel antidiabetic/antiobesty drugs as innovative pharmacotherapeutic tools for cardioprotection in experimental model of type 2 diabetes
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
  • Cardiovascular protection mediated by alpha 1 AMPK against metabolic syndrome-mediated endothelial dysfunction - identifying new risk factors
    Program: SRDA
    Duration: 1. 7. 2023 – 30. 6. 2027
  • Targeted suppression of pro-inflammatory and pro-fibrotic signaling pathways to prevent heart failure and occurrence of malignant arrhythmias
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2026
  • New aspects of cardioprotection by natural antioxidants: role of ageing and lifestyle-related comorbidities
    Program: SRDA
    Duration: 1. 7. 2022 – 30. 6. 2026
  • Development of diabetic nephropathy and its treatment with nutraceutic in experimental conditions
    Program: VEGA
    Duration: 1. 1. 2022 – 31. 12. 2025
  • Necroptotic and pleiotropic effects of RIP3 kinase acting as a convergent point in cardiac cell loss: understanding the basic mechanisms in the ischemic heart with or without metabolic stress as a tool for designing therapeutic approaches.
    Program: SRDA
    Duration: 1. 7. 2021 – 30. 6. 2025
Finished
  • The role of miRNAs in the onset and progression of cardiovascular diseases - new approach to the protection of the heart in situations of increased production of reactive oxygen species
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
  • Study of new mechanisms of cardioprotection against ischemia-reperfusion injury of the heart: role of extracellular vesicles, non-coding RNAs and impact of metabolic co-morbidities on these mechanisms
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • The role of matrix metalloproteinases in pathophysiology of cardiovascular system diseases and their relation to cellular redox signaling.
    Program: SRDA
    Duration: 1. 7. 2019 – 30. 6. 2023
  • Role of Nrf2 signaling pathway in responses of cardiac cells to pathological conditions
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2020
  • The role of extracellular vesicles in inter-organ communication related to remote cardioprotection
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2019
Employees